Recombinant multi-species DMKN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DMKN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is upregulated in inflammatory diseases, and it was first observed as expressed in the differentiated layers of skin. The most interesting aspect of this gene is the differential use of promoters and terminators to generate isoforms with unique cellular distributions and domain components. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
The Alternative Names of target: DMKN,Dermokine,Epidermis-specific secreted protein SK30/SK89,UNQ729,ZD52F10

Target products collectionGo to DMKN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0890-Ab-1/ GM-Tg-hg-SE0890-Ab-2 Human DMKN protein Human
GM-Tg-rg-SE0890-Ab-1/ GM-Tg-rg-SE0890-Ab-2 Rat DMKN protein Rat
GM-Tg-mg-SE0890-Ab-1/ GM-Tg-mg-SE0890-Ab-2 Mouse DMKN protein Mouse
GM-Tg-cynog-SE0890-Ab-1/ GM-Tg-cynog-SE0890-Ab-2 Cynomolgus/Rhesus macaque DMKN monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0890-Ab-1/ GM-Tg-felg-SE0890-Ab-2 Feline DMKN protein Feline
GM-Tg-cang-SE0890-Ab-1/ GM-Tg-cang-SE0890-Ab-2 Canine DMKN protein Canine
GM-Tg-bovg-SE0890-Ab-1/ GM-Tg-bovg-SE0890-Ab-2 Bovine DMKN protein Bovine
GM-Tg-equg-SE0890-Ab-1/ GM-Tg-equg-SE0890-Ab-2 Equine DMKN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0890-Ab-1/ GM-Tg-hg-SE0890-Ab-2; GM-Tg-rg-SE0890-Ab-1/ GM-Tg-rg-SE0890-Ab-2;
GM-Tg-mg-SE0890-Ab-1/ GM-Tg-mg-SE0890-Ab-2; GM-Tg-cynog-SE0890-Ab-1/ GM-Tg-cynog-SE0890-Ab-2;
GM-Tg-felg-SE0890-Ab-1/ GM-Tg-felg-SE0890-Ab-2; GM-Tg-cang-SE0890-Ab-1/ GM-Tg-cang-SE0890-Ab-2;
GM-Tg-bovg-SE0890-Ab-1/ GM-Tg-bovg-SE0890-Ab-2; GM-Tg-equg-SE0890-Ab-1/ GM-Tg-equg-SE0890-Ab-2
Products Name DMKN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DMKN
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DMKN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.